Join the Cervical Cancer group to help and get support from people like you.
Cervical Cancer News (Page 2)
Related terms: Cancer, Cervix
Task Force Supports Women Over 30 Collecting Samples for Cervical Cancer Screening
TUESDAY, Dec. 10, 2024 – In guidelines that may encourage more women to get screened for cervical cancer, a leading health task force has backed giving women over 30 the option to collect their own...
Screening Primary Driver of Averted Cancer Deaths From 1975 to 2020
TUESDAY, Dec. 10, 2024 – Over the past 45 years, cancer prevention and screening accounted for most cancer deaths averted for breast, cervical, colorectal, lung, and prostate cancers, according to a...
USPSTF Issues Draft Recommendation Statement for Cervical Cancer Screening
TUESDAY, Dec. 10, 2024 – The U.S. Preventive Services Task Force (USPSTF) recommends screening for cervical cancer, with different approaches recommended for those aged 21 to 29 years and 30 to 65...
Cervical Cancer Deaths Fell Dramatically After Advent of HPV Vaccine
MONDAY, Dec. 2, 2024 – A new study provides good evidence that the human papillomavirus (HPV) vaccine may be achieving its goal of slashing rates of cervical cancer. “We observed a … 62% drop in cer...
Women Want a Choice Between Vaginal HPV Self-Sampling and Clinician Screen
THURSDAY, Oct. 24, 2024 – Most women would like a choice between vaginal human papillomavirus (HPV) self-sampling and traditional clinician screening, although nearly half would prefer a...
AAO: Corneal Toxicity Reported With Mirvetuximab Soravtansine
TUESDAY, Oct. 22, 2024 – For patients receiving mirvetuximab soravtansine (MIRV) treatment for primary gynecologic malignancies, corneal toxicity is not uncommon, but usually resolves, according to...
Measures of Social Support Linked to Cancer Screening
MONDAY, Oct. 21, 2024 – Measures of social support are associated with screening for specific types of cancer, according to a study published online Oct. 18 in Cancer Causes & Control. Jordan Baeker...
New Drug Regimen Extends Survival for Cervical Cancer Patients
THURSDAY, Oct. 17, 2024 – In some good news for women battling locally advanced cervical cancer, new research shows that adding six weeks of chemotherapy to standard treatment cuts the risk of death...
MS Might Raise a Person's Odds for Cancer
THURSDAY, Oct. 10, 2024b – There's a small but significant increased of certain cancers in people battling multiple sclerosis (MS), new research shows. Those malignancies include cancers of the...
One-Dose HPV Vaccination Averts Similar Number of Cancers as Two Doses
MONDAY, Oct. 7, 2024 – A one-dose human papillomavirus (HPV) vaccination program is projected to prevent a similar number of cervical cancers as a two-dose program, according to a study published...
U.S. Cancer Incidence Trends Lower Than Expected in 2021
FRIDAY, Sept. 6, 2024 – U.S. cancer incidence trends improved in 2021, but continued to be lower than expected, according to a study published online Sept. 6 in JAMA Network Open. Todd Burus, from...
FDA Grants Full Approval for Tivdak to Treat Recurrent or Metastatic Cervical Cancer
NEW YORK & COPENHAGEN, Denmark--(BUSINESS WIRE) April 29, 2024 – Pfizer Inc. (NYSE: PFE) and Genmab A/S (Nasdaq: GMAB) today announced the U.S. Food and Drug Administration (FDA) approves the...
FDA Approves Merck’s Keytruda (pembrolizumab) Plus Chemoradiotherapy as Treatment for Patients With FIGO 2014 Stage III-IVA Cervical Cancer
Keytruda is the first and only anti-PD-1 therapy approved in combination with chemoradiotherapy for these patients Approval marks third FDA-approved indication for Keytruda in cervical cancer and...
FDA Approves Vegzelma (bevacizumab-adcd), a Biosimilar to Avastin
Vegzelma is Celltrion’s third oncology biosimilar to receive approval from the U.S. FDA Vegzelma offers U.S. patients living with multiple types of cancer a new, safe, and effective treatment option ...
FDA Approves Alymsys (bevacizumab-maly), a Biosimilar to Avastin
BRIDGEWATER, N.J.--(BUSINESS WIRE) April 13, 2022 --Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...